XML 43 R33.htm IDEA: XBRL DOCUMENT v3.19.1
Summary of Significant Accounting Policies - Stock-Based Compensation (Details)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Jul. 01, 2017
shares
Jun. 30, 2017
item
$ / shares
shares
Feb. 28, 2017
item
$ / shares
shares
Aug. 31, 2016
item
$ / shares
shares
Mar. 31, 2019
USD ($)
item
$ / shares
shares
Mar. 31, 2018
USD ($)
$ / shares
Sep. 30, 2018
USD ($)
Dec. 31, 2018
$ / shares
shares
Jun. 30, 2018
shares
Stock plans disclosure                  
Cash received for exercise of stock options | $         $ 68,000 $ 2,259,000      
ESPP                  
Weighted-average assumptions used to estimate the fair value of each stock option                  
Dividend (as a percent)         0.00%        
Volatility (as a percent)         67.30%        
Risk-free interest rate (as a percent)         2.51%        
Expected life         6 months        
Weighted-Average Grant Date Fair Value                  
Awarded (in dollars per share) | $ / shares         $ 1.63        
Stock plans disclosure                  
Aggregate number of common shares reserved for future issuance                 1,000,000
Estimated subscriptions outstanding         242,000        
Stock compensation expense | $         $ 197,000        
Stock options and restricted stock awards                  
Stock plans disclosure                  
Stock compensation expense | $         5,000,000   $ 3,700,000    
Estimated fair value that could be expensed | $         $ 38,800,000        
Stock options                  
Weighted-average assumptions used to estimate the fair value of each stock option                  
Dividend (as a percent)         0.00% 0.00%      
Volatility (as a percent)         73.57% 70.82%      
Risk-free interest rate (as a percent)         2.47% 2.70%      
Expected life         6 years 6 years      
Weighted-average grant date fair value (in dollars per share) | $ / shares         $ 3.46 $ 10.55      
Number of Stock Options                  
Outstanding at the beginning of the period (in shares)         15,564,000        
Granted (in shares)         4,840,000        
Exercised (in shares)         (25,000)        
Forfeited/Canceled (in shares)         (195,000)        
Outstanding at the end of the period (in shares)         20,184,000     15,564,000  
Weighted-Average Exercise Price                  
Outstanding at the beginning of the period (in dollars per share) | $ / shares         $ 10.20        
Granted (in dollars per share) | $ / shares         5.25        
Exercised (in dollars per share) | $ / shares         2.73        
Forfeited/Canceled (in dollars per share) | $ / shares         9.68        
Outstanding at the end of the period (in dollars per share) | $ / shares         $ 9.03     $ 10.20  
Stock plans disclosure                  
Cash received for exercise of stock options | $         $ 68,000        
Stock options | Minimum                  
Weighted-Average Exercise Price                  
Exercised (in dollars per share) | $ / shares         $ 2.03        
Stock options | Maximum                  
Weighted-Average Exercise Price                  
Exercised (in dollars per share) | $ / shares         $ 3.05        
Performance shares                  
Stock-Based Compensation                  
Exercise period               5 years  
Number of equal installments restrictions lapse               2  
Number of Restricted Stock Shares                  
Awarded (in shares)               295,200  
Stock plans disclosure                  
Stock compensation expense | $         $ 0        
Estimated fair value that could be expensed | $         $ 1,700,000        
Restricted stock                  
Stock-Based Compensation                  
Number of equal installments restrictions lapse | item   3 3 3          
Number of Restricted Stock Shares                  
Unvested at the beginning of the period (in shares)         1,816,000        
Awarded (in shares)         13,000        
Vested (in shares)         (485,000)        
Forfeited (in shares) (71,380)                
Unvested at the end of the period (in shares)         1,344,000     1,816,000  
Weighted-Average Grant Date Fair Value                  
Unvested at the beginning of the period (in dollars per share) | $ / shares         $ 2.87        
Vested (in dollars per share) | $ / shares         2.52        
Unvested at the end of the period (in dollars per share) | $ / shares         $ 2.99     $ 2.87  
Restricted stock | Officers                  
Number of Restricted Stock Shares                  
Awarded (in shares)   239,000 529,830 117,800          
Weighted-Average Grant Date Fair Value                  
Awarded (in dollars per share) | $ / shares   $ 4.71 $ 2.47 $ 3.15          
Stock plans disclosure                  
Stock compensation expense | $         $ 0        
Estimated fair value that could be expensed | $         $ 2,600,000        
2016 Plan | Stock options                  
Weighted-average assumptions used to estimate the fair value of each stock option                  
Number of group of awards for which expected term is calculated for and applied | item         1        
2016 Plan | Stock options | Maximum                  
Stock-Based Compensation                  
Vesting period         4 years        
Exercise period         10 years        
2018 Plan                  
Stock-Based Compensation                  
Common stock authorized for issuance (in shares)         7,500,000        
Previous stock option plans                  
Stock-Based Compensation                  
Common stock authorized for issuance (in shares)         19,500,000